Abstract

The Southeastern Cancer Study Group is a multi-modality, interdisciplinary, multi-institutional group organized to conduct trials of therapeutic regimens for the treatment of cancer. Studies are concerned with all stages and sites except for central nervous system and pediatric tumors. Emphasis has shifted from palliative therapy of late stage hematologic malignancies to protocols with curative intent for early stage, poor risk solid tumors. In order to upgrade the quality and relevance of work, additional efforts are proposed in quality control for medical, surgical and radiation oncology, pathology review, steroid receptors and phase I studies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA019657-10S1
Application #
3556430
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1977-08-01
Project End
1989-07-31
Budget Start
1985-08-01
Budget End
1989-07-31
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294

  Publications

Omura, G A; Vogler, W R; Martelo, O et al. (1994) Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience. Leuk Lymphoma 15:71-8
Balch, C M; Urist, M M; Karakousis, C P et al. (1993) Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 218:262-7;discussion 267-9
Martelo, O J; Omura, G A; Gordon, D S et al. (1992) Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience. Am J Clin Oncol 15:61-8
Zuckerman, K S; LoBuglio, A F; Reeves, J A (1990) Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with a high-dose doxorubicin-containing regimen. J Clin Oncol 8:248-56
Lazarus, H M; Vogler, W R; Burns, C P et al. (1989) High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group. Cancer 63:1055-9
Wittliff, J L; Day Jr, T G; Dean, W L et al. (1988) Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors. Prog Clin Biol Res 276:11-41
Seitz, D E; Loehrer Sr, P J; Williams, S D et al. (1988) Chemotherapeutic approaches to the treatment of testicular cancer. Semin Urol 6:238-45
Kramer, B S; Birch, R; Greco, A et al. (1988) Randomized phase II evaluation of iproplatin (CHIP) and carboplatin (CBDCA) in lung cancer. A Southeastern Cancer Study Group trial. Am J Clin Oncol 11:643-5
Einhorn, L H (1987) Chemotherapy of disseminated germ cell tumors. Cancer 60:570-3
Keller, J W; Omura, G A; Gams, R A et al. (1987) Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial. Am J Clin Oncol 10:194-5

Showing the most recent 10 out of 58 publications